Relationship Between Chloroquine or Hydroxychloroquine Use and Hearing Disorders: A Systematic Review and Meta-Analysis.

IF 1.1 Q3 OTORHINOLARYNGOLOGY

Journal of Audiology and Otology Pub Date : 2024-04-01 Epub Date: 2024-02-22 DOI:10.7874/jao.2023.00157

Maria Renata José, Jéssica da Silva Ortega, Jordana Batista Correia Baran, Débora Lüders, Claudia Giglio de Oliveira Gonçalves, Bianca Simone Zeigelboim, Karinna Veríssimo Meira Taveira, José Fernando Polanski, Rosane Sampaio Santos, Camila de Castro Corrêa, Cristiano Miranda de Araujo

{"title":"Relationship Between Chloroquine or Hydroxychloroquine Use and Hearing Disorders: A Systematic Review and Meta-Analysis.","authors":"Maria Renata José, Jéssica da Silva Ortega, Jordana Batista Correia Baran, Débora Lüders, Claudia Giglio de Oliveira Gonçalves, Bianca Simone Zeigelboim, Karinna Veríssimo Meira Taveira, José Fernando Polanski, Rosane Sampaio Santos, Camila de Castro Corrêa, Cristiano Miranda de Araujo","doi":"10.7874/jao.2023.00157","DOIUrl":null,"url":null,"abstract":"Background and objectives: Chloroquine and its analog hydroxychloroquine are derivatives of 4-aminoquinoline and are regularly used in the treatment of malaria and autoimmune diseases. Among the side effects of these drugs, alterations associated with the auditory system are frequently mentioned. Thus, the aim of this systematic review is to systematically review publications on hearing disorders and chloroquine or hydroxychloroquine use.Materials and methods: Inclusion criteria were observational or interventional studies on audiological assessment in participants who were using chloroquine or hydroxychloroquine. The methodological quality was independently assessed by two reviewers using the Meta-Analysis of Statistics: assessment and review Instrument. The certainty of the evidence was assessed using the GRADE tool.Results: A total of 1,372 non-duplicate papers were screened, out of which 17 were included in the final qualitative synthesis, and 5 studies in the meta-analysis. The odds ratio for the two subgroups evaluated did not show significance with no heterogeneity between the effects observed between the different diseases (I2=0%) and obtaining the global estimate of 0.76 (95% confidence interval [CI]=0.41-1.39; p>0.05). Despite the inclusion of papers with different disease samples, the heterogeneity observed in the analysis was low (I2= 0%) and prediction interval (95% PI=0.32-1.80; p>0.05) remained close to that estimated by the CI (95% CI=0.41-1.39; p>0.05). The certainty of the evidence assessed by the GRADE tool was considered very low due to the risk of bias, indirect evidence, and imprecision.Conclusions: The findings of this study suggest that the use of chloroquine/hydroxychloroquine is not associated with hearing disorders.","PeriodicalId":44886,"journal":{"name":"Journal of Audiology and Otology","volume":" ","pages":"126-145"},"PeriodicalIF":1.1000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065553/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Audiology and Otology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7874/jao.2023.00157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objectives: Chloroquine and its analog hydroxychloroquine are derivatives of 4-aminoquinoline and are regularly used in the treatment of malaria and autoimmune diseases. Among the side effects of these drugs, alterations associated with the auditory system are frequently mentioned. Thus, the aim of this systematic review is to systematically review publications on hearing disorders and chloroquine or hydroxychloroquine use.

Materials and methods: Inclusion criteria were observational or interventional studies on audiological assessment in participants who were using chloroquine or hydroxychloroquine. The methodological quality was independently assessed by two reviewers using the Meta-Analysis of Statistics: assessment and review Instrument. The certainty of the evidence was assessed using the GRADE tool.

Results: A total of 1,372 non-duplicate papers were screened, out of which 17 were included in the final qualitative synthesis, and 5 studies in the meta-analysis. The odds ratio for the two subgroups evaluated did not show significance with no heterogeneity between the effects observed between the different diseases (I2=0%) and obtaining the global estimate of 0.76 (95% confidence interval [CI]=0.41-1.39; p>0.05). Despite the inclusion of papers with different disease samples, the heterogeneity observed in the analysis was low (I2= 0%) and prediction interval (95% PI=0.32-1.80; p>0.05) remained close to that estimated by the CI (95% CI=0.41-1.39; p>0.05). The certainty of the evidence assessed by the GRADE tool was considered very low due to the risk of bias, indirect evidence, and imprecision.

Conclusions: The findings of this study suggest that the use of chloroquine/hydroxychloroquine is not associated with hearing disorders.

查看原文本刊更多论文

使用氯喹或羟氯喹与听力障碍之间的关系：系统回顾与元分析》。

背景和目的：氯喹及其类似物羟氯喹是 4-氨基喹啉的衍生物，经常用于治疗疟疾和自身免疫性疾病。在这些药物的副作用中，与听觉系统相关的改变经常被提及。因此，本系统综述旨在系统回顾有关听力障碍和氯喹或羟氯喹使用的出版物：纳入标准是对使用氯喹或羟氯喹的参与者进行听力评估的观察性或干预性研究。方法学质量由两名审稿人使用 "统计元分析：评估和审查工具 "进行独立评估。证据的确定性采用 GRADE 工具进行评估：共筛选出 1,372 篇非重复论文，其中 17 篇纳入最终定性综合，5 篇纳入荟萃分析。所评估的两个亚组的几率比并没有显示出显著性，不同疾病之间所观察到的效果也没有异质性（I2=0%），总体估计值为 0.76（95% 置信区间 [CI]=0.41-1.39; p>0.05）。尽管纳入了不同疾病样本的论文，但分析中观察到的异质性很低（I2= 0%），预测区间（95% PI=0.32-1.80；P>0.05）仍然接近 CI（95% CI=0.41-1.39；P>0.05）的估计值。由于存在偏倚风险、间接证据和不精确性，GRADE 工具评估的证据确定性很低：本研究结果表明，使用氯喹/羟氯喹与听力障碍无关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Audiology and Otology OTORHINOLARYNGOLOGY-

CiteScore

1.90

自引率

9.10%

发文量

期刊介绍： Journal of Audiology and Otology (JAO) (formerly known as Korean Journal of Audiology) aims to publish the most advanced findings for all aspects of the auditory and vestibular system and diseases of the ear using state-of-the-art techniques and analyses. The journal covers recent trends related to the topics of audiology, otology, and neurotology conducted by professionals, with the goal of providing better possible treatment to people of all ages, from infants to the elderly, who suffer from auditory and/or vestibular disorders and thus, improving their quality of life. This journal encourages the submission of review papers about current professional issues, research papers presenting a scientific base and clinical application, and case papers with unique reports or clinical trials. We also invite letters to the editor and papers related to the manufacture and distribution of medical devices. This journal provides integrated views from otologists, audiologists, and other healthcare practitioners, offering readers high quality scientific and clinical information. This peer-reviewed and open access journal has been the official journal of the Korean Audiological Society since 1997 and of both the Korean Audiological Society and the Korean Otological Society since 2017. It is published in English four times a year in January, April, July, and October.